Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. (bmj.com)

Authors: Cai M … Al-Aly Z Journal: BMJ Published: 2026-03-04 DOI: https://doi.org/10.1136/bmj-2025-086886